These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8243040

  • 41. A comparative study of the effect of oral treatment with augmentin, amoxycillin and bacampicillin on the faecal flora in mice.
    Hofstra W, Welling GW, Van der Waaij D.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jul; 269(1):78-85. PubMed ID: 3051802
    [Abstract] [Full Text] [Related]

  • 42. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Traub WH, Leonhard B.
    Chemotherapy; 1995 Jul; 41(5):345-52. PubMed ID: 8521736
    [Abstract] [Full Text] [Related]

  • 43. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
    Aguilar L, Martín M, Balcabao IP, Gómez-Lus ML, Dal-Ré R, Prieto J.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
    [Abstract] [Full Text] [Related]

  • 44. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A, Räder K.
    Arzneimittelforschung; 1991 Jan; 41(1):70-3. PubMed ID: 2049115
    [Abstract] [Full Text] [Related]

  • 45. [The inhibitor effect of the ampicillin-sulbactam combination on Enterobacteriaceae resistant to ampicillin].
    Poiată A, Diculencu D, Buiuc D.
    Bacteriol Virusol Parazitol Epidemiol; 1992 Jan; 37(1-2):67-9. PubMed ID: 1472781
    [No Abstract] [Full Text] [Related]

  • 46. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W, Binder S, Stieglitz M.
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [Abstract] [Full Text] [Related]

  • 47. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
    Bedenić B, Zagar Z.
    J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
    [Abstract] [Full Text] [Related]

  • 48. Antimicrobial activity of cefoperazone with clavulanic acid or sulbactam against Enterobacteriaceae.
    Nagy E, Hajdu E, Földes J.
    J Antimicrob Chemother; 1990 Apr; 25(4):701-3. PubMed ID: 2351631
    [No Abstract] [Full Text] [Related]

  • 49. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV, Aldridge KE.
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [Abstract] [Full Text] [Related]

  • 50. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.
    Legrand P, Fournier G, Buré A, Jarlier V, Nicolas MH, Decré D, Duval J, Philippon A.
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):527-9. PubMed ID: 2504594
    [Abstract] [Full Text] [Related]

  • 51. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [Abstract] [Full Text] [Related]

  • 52. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
    Jacobs MR, Aronoff SC, Johenning S, Yamabe S.
    J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
    [Abstract] [Full Text] [Related]

  • 53. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ, Ponticas S, Shungu DL, Guerriero S.
    Clin Ther; 1991 Aug; 13(1):25-37. PubMed ID: 2029725
    [Abstract] [Full Text] [Related]

  • 54. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
    Focht J, Klietmann W, Nösner K, Rolinson GN, Johnsen J.
    Chemotherapy; 1988 Aug; 34(4):332-40. PubMed ID: 3264780
    [Abstract] [Full Text] [Related]

  • 55. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV, Tubert TA.
    Diagn Microbiol Infect Dis; 1990 Aug; 13(4):349-52. PubMed ID: 2127558
    [Abstract] [Full Text] [Related]

  • 56. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Kacmaz B, Sultan N.
    Jpn J Infect Dis; 2007 Jul; 60(4):227-9. PubMed ID: 17642541
    [Abstract] [Full Text] [Related]

  • 57. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS, Hall LM, Livermore DM.
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [Abstract] [Full Text] [Related]

  • 58. [False sensitivity of Enterococcus faecium to amoxicillin-clavulanic acid with the MicroScan system].
    Joyanes P, Pascual A, Suárez AI, Martínez-Martínez L.
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):96-8. PubMed ID: 7711133
    [Abstract] [Full Text] [Related]

  • 59. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
    Stapleton P, Wu PJ, King A, Shannon K, French G, Phillips I.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2478-83. PubMed ID: 8585729
    [Abstract] [Full Text] [Related]

  • 60. Ampicillin-sulbactam susceptibility testing criteria.
    Barry A, Pfaller M, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):469-72. PubMed ID: 8359171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.